Table 4

- Resistance patterns of Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates, stratified by gender.

Species	Antibiotic ↓	Males		Females		P-values
Species	Antibiotic ↓	No. of isolates tested	Non-susceptible	No. of isolates tested	Non-susceptible	P-values
E. coli	Ampicillin	41	33 (80.5)*	324	200 (61.7)	0.018
	Ceftriaxone	46	17 (37.0)*	412	88 (21.4)	0.016
	Ciprofloxacin	42	22 (52.4)*	398	93 (23.4)	<0.001
	Imipenem	17	0 (0.0)*	88	0 (0.0)	N/A
	Meropenem	17	0 (0.0)*	89	0 (0.0)	N/A
	Nitrofurantoin	42	1 (2.4)*	407	15 (3.7)	0.664
	TZP	8	0 (0.0)*	54	3 (5.6)	0.494
	TMP/SMX	44	21 (47.7)*	412	152 (36.9)	0.159
	Gentamicin	26	0 (0.0)*	122	9 (7.4)	0.153
	Amox-clav	9	2 (22.2)*	62	18 (29.0)	0.671
K. pneumonia	Ampicillin	25	25 (100)	49	49 (100)	N/A
	Ceftriaxone	26	10 (38.5)	47	9 (19.1)	0.071
	Ciprofloxacin	19	10 (52.6)	43	13 (30.2)	0.092
	Imipenem	10	0 (0.0)	9	0 (0.0)	N/A
	Meropenem	10	0 (0.0)	9	0 (0.0)	N/A
	Nitrofurantoin	20	13 (65.0)	44	27 (61.4)	0.780
	TZP	5	1 (20.0)	4	0 (0.0)	0.342
	TMP/SMX	19	14 (73.7)	44	9 (20.4)	<0.001
	Gentamicin	21	1 (4.8)	22	2 (9.1)	0.577
	Amox-clav	6	1 (16.7)	6	1 (16.7)	1
P. mirabilis	Ampicillin	5	2 (40.0)	13	6 (46.1)	0.882
	Ceftriaxone	6	1 (16.7)	15	2 (13.3)	0.865
	Ciprofloxacin	6	1 (16.7)	15	2 (13.3)	0.865
	Imipenem	1	0 (0.0)	1	1 (100)	0.386
	Meropenem	2	0 (0.0)	2	0 (0.0)	N/A
	Nitrofurantoin	6	6 (100)	15	15 (100)	1
	TMP/SMX	6	2 (33.3)	15	4 (26.7)	0.821
	Gentamicin	4	0 (0.0)	3	1 (33.3)	0.286
	Amox-clav	1	1 (100)	3	1 (33.3)	0.540

Values are presented as numbers and percentages (%). *Non-susceptibility includes resistant and intermediate susceptibility isolates.

E. coli: Escherichia coli, K. pneumoniae: Klebsiella pneumoniae, P. mirabilis: Proteus mirabilis, TZP: piperacillin-tazobactam,

TMP/SMX: trimethoprim-sulfamethoxazole, Amox-clav: amoxicillin and clavulanate, N/A: not available